Clinical Trials
29 trialsNCT04529122 2026-05-27
A Worldwide Cancer Registry Enrolling Participants Profiled With a Next-Generation Sequencing Test
Hoffmann-La Roche
Completed
NCT06885424 2026-05-20
DESCENT-1
A2 Biotherapeutics Inc.
Enrolling by invitation
NCT07562347 2026-05-01
ENCOMPASS STUD
IR INNOVATE RESEARCH PRIVATE LIMITED
Not yet recruiting
NCT04981119 2026-04-30
BASECAMP-1
A2 Biotherapeutics Inc.
Recruiting
NCT04142437 2026-04-14
ON-TRK
Bayer
Recruiting
NCT04945330 2026-04-14
NTRK Gene Fusion - Positive Advanced or Recurrent Solid Tumors, a Rare Cancer Caused by Specific Changes in the Genes
Bayer
Recruiting
NCT05461430 2026-04-13
TraveraRTGx
Travera Inc
Completed
NCT06805461 2026-03-30
PumaRx
RenovoRx
Recruiting
NCT00571389 2026-03-18
A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.
BioCytics, Inc.
Recruiting
NCT05538806 2025-08-22
TIGER Meso
NovoCure Ltd.
Recruiting
NCT06665776 2025-07-30
HLA-A*02:01 Allele Frequency and the NY-ESO-1 Expression Status in Cancer Patients in Taiwan
PharmaEssentia
Recruiting
NCT03517917 2025-05-23
Prospective Tissue Collection Research Protocol
AstraZeneca
Completed
NCT05324436 2025-01-20
A Study of Yervoy and Opdivo Combination Therapy in Participants With Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma (MPM)
Bristol-Myers Squibb
Completed
NCT04028479 2024-12-18
ROOT
Taproot Health
Completed
NCT04985357 2024-11-25
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
Withdrawn
NCT04843007 2024-10-23
Alvopem® (Pemetrexed) Safety Assessment
NanoAlvand
Completed
NCT05192642 2023-11-14
A Study Called VICTORIA to Learn More About How Well Larotrectinib Works in Adults With TRK Fusion-positive Cancer by Comparing Larotrectinib Data From Clinical Studies With Data of Other Treatments From Actual Practice
Bayer
Completed
NCT05793281 2023-10-25
An Observational Study to Learn More About NTRK Gene Fusion Positive in Solid Tumor in Japan
Bayer
Completed
NCT05819580 2023-04-25
Studying the Clinical Trial Experiences of Patients With Mesothelioma
Power Life Sciences Inc.
Not yet recruiting
NCT02555735 2023-02-01
Exceptional Responders With Solid Tumor Cancer to Chemotherapy
Adera Labs, LLC
Enrolling by invitation
NCT04976803 2022-08-01
ATM
Artios Pharma Ltd
Completed
NCT04811443 2021-03-23
DEFENDOR
Biocad
Unknown
NCT02678754 2020-01-23
CMIR
Caris Science, Inc.
Terminated
NCT01998607 2018-01-09
Survey of XGEVA® Presrcibers in Europe to Evaluate Their Knowledge of the Summary of Product Characteristics Pertaining to Osteonecrosis of the Jaw
Amgen
Completed
NCT01770665 2016-09-16
MiCK Assay
Pierian Biosciences
Terminated
NCT01209091 2016-02-03
Utility and Work Productivity Data for Economic Evaluation of Breast Cancer Therapies in the Netherlands and Sweden
GlaxoSmithKline
Completed
NCT01627990 2015-07-24
Nivestim™ in Treatment of Malignant Diseases
Hospira, now a wholly owned subsidiary of Pfizer
Completed
NCT00785239 2015-06-25
CryoSpray Ablation(tm)Thoracic Patient Registry
CSA Medical, Inc.
Withdrawn
NCT01271959 2012-10-05
A Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study
Precision Therapeutics
Terminated